Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.
It is presently not clear if ovarian carcinomas arise de novo or from benign precursors (cystadenomas) and if high-grade malignant tumors (carcinomas) develop from preexisting low-grade carcinomas. The presence of allelic losses on chromosome 11p15.5 distinguishes high-grade ovarian carcinomas from either low-grade carcinomas or cystadenomas. We therefore examined the distribution of such losses in different parts of heterogeneous tumors showing mixed histological grades or showing adjacent large histologically benign neoplasms. The results showed that all neoplastic areas, including those that were histologically benign or compatible with low-grade carcinomas, contained allelic losses at the above locus. This suggests that the morphologically less aggressive portions of these heterogeneous tumors were not typical cystadenomas or low-grade carcinomas and contained molecular abnormalities indicative of at least a predisposition to the high-grade carcinoma phenotype.
Zheng
J
J
Department of Pathology, Kenneth Norris Jr. Comprehensive Cancer Center, USC School of Medicine, Los Angeles 90033.
Wan
M
M
Zweizig
S
S
Velicescu
M
M
Yu
M C
MC
Dubeau
L
L
D000483:Alleles; D001483:Base Sequence; D002277:Carcinoma / Q000235:genetics / Q000473:pathology*; D002872:Chromosome Deletion; D002880:Chromosomes, Human, Pair 11; D003537:Cystadenoma / Q000473:pathology; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology*